Impact of Zostavax Vaccination on T-Cell Accumulation and Cutaneous Gene Expression in the Skin of Older Humans After Varicella Zoster Virus Antigen–Specific Challenge

BACKGROUND: The live attenuated vaccine Zostavax was developed to prevent varicella zoster virus (VZV) reactivation that causes herpes zoster (shingles) in older humans. However, the impact of vaccination on the cutaneous response to VZV is not known. METHODS: We investigated the response to intrade...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Neil P, Vukmanovic-Stejic, Milica, Suarez- Farinas, Mayte, Chambers, Emma S, Sandhu, Daisy, Fuentes-Duculan, Judilyn, Mabbott, Neil A, Rustin, Malcolm H A, Krueger, James, Akbar, Arne N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/
https://www.ncbi.nlm.nih.gov/pubmed/30247603
http://dx.doi.org/10.1093/infdis/jiy420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/
https://www.ncbi.nlm.nih.gov/pubmed/30247603
http://dx.doi.org/10.1093/infdis/jiy420

Ejemplares similares